Published in J Consult Clin Psychol on December 01, 1988
CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial. Trials (2014) 1.42
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J (2008) 1.18
Unipolar late-onset depression: A comprehensive review. Ann Gen Hosp Psychiatry (2003) 0.99
Recognition of depression in older medical inpatients. J Gen Intern Med (2007) 0.91
Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial. CMAJ (2005) 0.90
The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions. Ann Gen Psychiatry (2010) 0.76
An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem (1968) 8.62
Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1971) 4.41
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49
Purification and properties of rabbit skeletal muscle adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1971) 3.18
The genome of Salinibacter ruber: convergence and gene exchange among hyperhalophilic bacteria and archaea. Proc Natl Acad Sci U S A (2005) 2.43
Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) (2004) 2.33
Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum (2003) 2.15
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase. J Biol Chem (1972) 2.13
The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials (1998) 2.09
Purification and properties of chicken liver D-3-phosphoglycerate dehydrogenase. Biochemistry (1965) 2.08
Effects of pulsed ultrasound and temperature on the development of rat embryos in culture. Teratology (1990) 2.07
Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem (1989) 1.89
Catlysis of the phosphrylaseinase actition reaction. J Biol Chem (1971) 1.89
Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage (2012) 1.74
Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase. J Biol Chem (1971) 1.72
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature (1988) 1.66
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem (1983) 1.61
Inactivation of glycogen synthetase and activation of phosphorylase kinase by muscle adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1970) 1.57
Phosphorylation of Avena phytochrome in vitro as a probe of light-induced conformational changes. J Biol Chem (1986) 1.53
Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. Front Biosci (1999) 1.50
A cyclic 3',5'-amp-stimulated protein kinase from cardiac muscle. Adv Enzyme Regul (1970) 1.44
Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. J Biol Chem (1983) 1.43
Comparative studies on the pathways for serine biosynthesis in animal tissues. J Biol Chem (1966) 1.40
Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am J Physiol (1992) 1.38
A rapid method for the measurement of [gamma-32P]ATP specific radioactivity in tissue extracts and its application to the study of 32Pi uptake in perfused rat heart. Anal Biochem (1976) 1.37
Activation of adipose tissue lipase by skeletal muscle cyclic adenosine 3',5'- monophosphate-stimulated protein kinase. J Biol Chem (1970) 1.36
Multiple forms of hepatic adenosine 3':5'-monophosphate dependent protein kinase. Biochemistry (1971) 1.35
Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem (1989) 1.32
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme. J Biol Chem (1973) 1.32
Family networks: predictors of nursing home entry. Am J Public Health (1994) 1.30
Measuring adherence to behavioral and medical interventions. Control Clin Trials (2000) 1.25
Possibility of shape conformers of the protein inhibitor of the cyclic adenosine monophosphate dependent protein kinase. Biochemistry (1979) 1.24
The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol (1996) 1.22
An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J (1985) 1.21
The elementary reactions of the pig heart pyruvate dehydrogenase complex. A study of the inhibition by phosphorylation. Biochem J (1976) 1.21
Detection of methicillin-resistant Staphylococcus aureus by microdilution and disk elution susceptibility systems. J Clin Microbiol (1984) 1.20
Diagnosed skin diseases among migrant farmworkers in North Carolina: prevalence and risk factors. J Agric Saf Health (2007) 1.19
Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage (2007) 1.18
The interrelationship between cAMP-dependent alpha and beta subunit phosphorylation in the regulation of phosphorylase kinase activity. Studies using subunit specific phosphatases. J Biol Chem (1987) 1.17
Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem (1986) 1.16
Some teratogenic properties of ethanol and acetaldehyde in C57BL/6J mice: implications for the study of the fetal alcohol syndrome. Teratology (1983) 1.15
Protein kinases: aspects of their regulation and diversity. Recent Prog Horm Res (1973) 1.14
Four- and six-month-old infants' visual responses to joy, anger, and neutral expressions. Child Dev (1976) 1.11
Lengthy incubation for homosexual transmission of acquired immunodeficiency syndrome in a 79 year old man. Postgrad Med J (1989) 1.10
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthritis Cartilage (2010) 1.08
Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol (2004) 1.07
Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience (1993) 1.07
Physiochemical properties of rabbit skeletal muscle phosphorylase kinase. Biochemistry (1973) 1.07
The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. Mol Endocrinol (1992) 1.04
Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase. Biochemistry (1985) 1.04
Subunit phosphorylation and activation of skeletal muscle phosphorylase kinase by the cAMP-dependent protein kinase. Divalent metal ion, ATP, and protein concentration dependence. J Biol Chem (1985) 1.04
Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1991) 1.03
Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis (1994) 1.03
The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol (1997) 1.03
Nuclear protein kinase activity in glucagon-stimulated perfused rat livers. Biochem J (1974) 1.03
Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol (1996) 1.02
A fast-twitch oxidative-glycolytic muscle with a robust inward calcium current. Can J Physiol Pharmacol (1985) 1.02
Solution structure of the cAMP-dependent protein kinase catalytic subunit and its contraction upon binding the protein kinase inhibitor peptide. Biochemistry (1993) 1.02
Antiinflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogues. J Med Chem (1984) 1.01
Self-efficacy, aftercare and relapse in a treatment program for alcoholics. J Stud Alcohol (1992) 1.01
Utilization of the inhibitor protein of adenosine cyclic monophosphate-dependent protein kinase, and peptides derived from it, as tools to study adenosine cyclic monophosphate-mediated cellular processes. Methods Enzymol (1991) 1.01
Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem (1992) 1.01
Skin disease among Latino farmworkers in North Carolina. J Agric Saf Health (2006) 1.00
Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol (1988) 1.00
Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. Eur Respir J (1999) 0.99
Nuclear protein-kinase activity in perfused rat liver stimulated with dibutyryl-adenosine cyclic 3':5'-monophosphate. Eur J Biochem (1975) 0.99
Inhibitor protein of the cAMP-dependent protein kinase: characteristics and purification. Methods Enzymol (1983) 0.99
Detecting depression in elderly medical inpatients. J Consult Clin Psychol (1988) 0.99
Alternative therapies commonly used within a population of patients with psoriasis. Cutis (1996) 0.98
Age differences in central perceptual processing: a dichoptic backward masking investigation. J Gerontol (1976) 0.98
Critical controls in the evaluation of cAMP-dependent protein kinase activity ratios as indices of hormonal action. J Biol Chem (1980) 0.98
The inhibitor protein of the cAMP-dependent protein kinase-catalytic subunit interaction. Parameters of complex formation. J Biol Chem (1986) 0.98
Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J (1989) 0.97
Nerve growth factor facilitates regeneration across nerve gaps: morphological and behavioral studies in rat sciatic nerve. Exp Neurol (1993) 0.97
Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthritis Cartilage (2009) 0.96
Heat-stable inhibitor protein derived peptide substrate analogs: phosphorylation by cAMP-dependent and cGMP-dependent protein kinases. Biochemistry (1995) 0.96
The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol (1992) 0.95
Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol (2008) 0.95
In situ regulation of cell-cell communication by the cAMP-dependent protein kinase and protein kinase C. Mol Cell Biochem (1993) 0.93
Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br J Pharmacol (1999) 0.93
Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1991) 0.93
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. J Med Chem (1997) 0.92
Cyclic AMP-dependent protein kinases from skeletal muscle and liver. Adv Cyclic Nucleotide Res (1972) 0.92
Hyperthermia and birth defects. Reprod Toxicol (1996) 0.91
Hyperthermia, teratogenesis and the heat shock response in mammalian embryos in culture. Int J Dev Biol (1997) 0.91
Fatal acute pyelonephritis following pulsed methylprednisolone for rheumatoid arthritis. Ann Rheum Dis (1990) 0.90
Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. J Med Chem (1999) 0.90
Circular dichroic investigations of secondary structure in synthetic peptide inhibitors of cAMP-dependent protein kinase: a model for inhibitory potential. Biochemistry (1987) 0.89
Phosphorylation and dephosphorylation of phosphorylase kinase in the perfused rat heart. J Biol Chem (1979) 0.89
Purification and characterization of an inhibitor protein of cyclic AMP-dependent protein kinases. Methods Enzymol (1974) 0.89
Criteria for the classification of protein kinases. Methods Enzymol (1974) 0.89
Analysis by mutagenesis of the ATP binding site of the gamma subunit of skeletal muscle phosphorylase kinase expressed using a baculovirus system. Biochemistry (1992) 0.89
Comorbid psychiatric disorders in elderly medical patients: a 1-year prospective study. J Am Geriatr Soc (1991) 0.89
Quaternary structures of a catalytic subunit-regulatory subunit dimeric complex and the holoenzyme of the cAMP-dependent protein kinase by neutron contrast variation. J Biol Chem (1998) 0.89
Age-related differences in two stages of central perceptual processes: the effects of short duration targets and criterion differences. J Gerontol (1979) 0.88
Characterization of multiple charge isomers of the inhibitor protein of the cyclic AMP-dependent protein kinase from bovine heart and rabbit skeletal muscle. Arch Biochem Biophys (1980) 0.88
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage (2013) 0.87
Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Biochemistry (1992) 0.87